Transcatheter Tricuspid Valve-in-Valve Implantation With a Novel Balloon Expandable Myval THV

Duran Karaduman B., Ayhan H., KELEŞ T., Bozkurt E.

Annals of Thoracic Surgery, vol.112, no.6, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 112 Issue: 6
  • Publication Date: 2021
  • Doi Number: 10.1016/j.athoracsur.2021.03.014
  • Journal Name: Annals of Thoracic Surgery
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Ankara Yıldırım Beyazıt University Affiliated: Yes

Abstract

© 2021 The Society of Thoracic SurgeonsThe transcatheter tricuspid valve-in-valve implantation has not yet been clarified, and several case series have documented results in patients with tricuspid bioprosthetic valve degeneration who underwent transcatheter implantation of Edwards SAPIEN XT and SAPIEN 3 (Edwards Lifesciences, Irvine, CA) and Medtronic (Minneapolis, MN) valves. Here, we present the case of a patient with severe bioprosthetic tricuspid valve stenosis who was successfully treated with the transfemoral route through the 29-mm novel balloon expandable Myval transcatheter heart valve (Meril Life Sciences Pvt Ltd, Vapi, Gujarat, India) system.